Investor & Analyst Day Breakfast, hosted by BioLineRx (BLRX)

The event will feature a presentation by key opinion leader (KOL) Talia Golan, MD (The Chaim Sheba Medical Center) who will discuss the current treatment landscape as well as the unmet medical need for treating patients with Metastatic Pancreatic Adenocarcinoma (PDAC). Dr. Golan will be available to answer questions at the conclusion of the event.